Baseline ctDNA gene alterations as a biomarker of survival after panitumumab and chemotherapy in metastatic colorectal cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Baseline ctDNA gene alterations as a biomarker of survival after panitumumab and chemotherapy in metastatic colorectal cancer ; volume:30 ; number:3 ; day:12 ; month:2 ; year:2024 ; pages:730-739 ; date:3.2024
Nature medicine ; 30, Heft 3 (12.2.2024), 730-739, 3.2024
- Urheber
-
Shitara, Kohei
Muro, Kei
Watanabe, Jun
Yamazaki, Kentaro
Ohori, Hisatsugu
Shiozawa, Manabu
Takashima, Atsuo
Yokota, Mitsuru
Makiyama, Akitaka
Akazawa, Naoya
Ojima, Hitoshi
Yuasa, Yasuhiro
Miwa, Keisuke
Yasui, Hirofumi
Oki, Eiji
Sato, Takeo
Naitoh, Takeshi
Komatsu, Yoshito
Kato, Takeshi
Mori, Ikuo
Yamanaka, Kazunori
Hihara, Masamitsu
Soeda, Junpei
Misumi, Toshihiro
Yamamoto, Kouji
Yamashita, Riu
Akagi, Kiwamu
Ochiai, Atsushi
Uetake, Hiroyuki
Tsuchihara, Katsuya
Yoshino, Takayuki
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41591-023-02791-w
- URN
-
urn:nbn:de:101:1-2405230725500.393307711989
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:01 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Shitara, Kohei
- Muro, Kei
- Watanabe, Jun
- Yamazaki, Kentaro
- Ohori, Hisatsugu
- Shiozawa, Manabu
- Takashima, Atsuo
- Yokota, Mitsuru
- Makiyama, Akitaka
- Akazawa, Naoya
- Ojima, Hitoshi
- Yuasa, Yasuhiro
- Miwa, Keisuke
- Yasui, Hirofumi
- Oki, Eiji
- Sato, Takeo
- Naitoh, Takeshi
- Komatsu, Yoshito
- Kato, Takeshi
- Mori, Ikuo
- Yamanaka, Kazunori
- Hihara, Masamitsu
- Soeda, Junpei
- Misumi, Toshihiro
- Yamamoto, Kouji
- Yamashita, Riu
- Akagi, Kiwamu
- Ochiai, Atsushi
- Uetake, Hiroyuki
- Tsuchihara, Katsuya
- Yoshino, Takayuki
- SpringerLink (Online service)
Ähnliche Objekte (12)
Biomarker alterations associated with distinct patterns of metastatic spread in colorectal cancer
Topoisomerase I copy number alterations as biomarker for irinotecan efficacy in metastatic colorectal cancer
Baseline and on-treatment markers determining prognosis of first-line chemotherapy in combination with bevacizumab in patients with metastatic colorectal cancer
Unsupported off-label chemotherapy in metastatic colon cancer
Changes in neutrophile-to-lymphocyte ratio as predictive and prognostic biomarker in metastatic prostate cancer treated with taxane-based chemotherapy
High baseline Tie1 level predicts poor survival in metastatic breast cancer
Artificial intelligence-enabled prediction of chemotherapy-induced cardiotoxicity from baseline electrocardiograms
Chemotherapy plus Panitumumab Versus Chemotherapy plus Bevacizumab in Metastatic Colorectal Cancer: A Meta-analysis
Platinum-based chemotherapy in metastatic prostate cancer: what possibilities?
Pembrolizumab plus azacitidine in patients with chemotherapy refractory metastatic colorectal cancer: a single-arm phase 2 trial and correlative biomarker analysis
Healthcare costs in patients with metastatic lung cancer receiving chemotherapy
Baseline circulating stem-like cells predict survival in patients with metastatic breast Cancer
Biomarker alterations associated with distinct patterns of metastatic spread in colorectal cancer
Topoisomerase I copy number alterations as biomarker for irinotecan efficacy in metastatic colorectal cancer
Baseline and on-treatment markers determining prognosis of first-line chemotherapy in combination with bevacizumab in patients with metastatic colorectal cancer
Unsupported off-label chemotherapy in metastatic colon cancer
Changes in neutrophile-to-lymphocyte ratio as predictive and prognostic biomarker in metastatic prostate cancer treated with taxane-based chemotherapy
High baseline Tie1 level predicts poor survival in metastatic breast cancer
Artificial intelligence-enabled prediction of chemotherapy-induced cardiotoxicity from baseline electrocardiograms
Chemotherapy plus Panitumumab Versus Chemotherapy plus Bevacizumab in Metastatic Colorectal Cancer: A Meta-analysis
Platinum-based chemotherapy in metastatic prostate cancer: what possibilities?
Pembrolizumab plus azacitidine in patients with chemotherapy refractory metastatic colorectal cancer: a single-arm phase 2 trial and correlative biomarker analysis
Healthcare costs in patients with metastatic lung cancer receiving chemotherapy
Baseline circulating stem-like cells predict survival in patients with metastatic breast Cancer
Biomarker alterations associated with distinct patterns of metastatic spread in colorectal cancer
Topoisomerase I copy number alterations as biomarker for irinotecan efficacy in metastatic colorectal cancer
Baseline and on-treatment markers determining prognosis of first-line chemotherapy in combination with bevacizumab in patients with metastatic colorectal cancer
Unsupported off-label chemotherapy in metastatic colon cancer
Changes in neutrophile-to-lymphocyte ratio as predictive and prognostic biomarker in metastatic prostate cancer treated with taxane-based chemotherapy
High baseline Tie1 level predicts poor survival in metastatic breast cancer
Artificial intelligence-enabled prediction of chemotherapy-induced cardiotoxicity from baseline electrocardiograms
Chemotherapy plus Panitumumab Versus Chemotherapy plus Bevacizumab in Metastatic Colorectal Cancer: A Meta-analysis
Platinum-based chemotherapy in metastatic prostate cancer: what possibilities?
Pembrolizumab plus azacitidine in patients with chemotherapy refractory metastatic colorectal cancer: a single-arm phase 2 trial and correlative biomarker analysis
Healthcare costs in patients with metastatic lung cancer receiving chemotherapy